Introduced in the Ohio Senate - January 2020
Passed out of the Ohio Senate Health, Human Services, and Medicaid Committee -March 2020
Signed into Law- January 2021
This bill would prohibit the use of telemedicine for the purpose of providing abortion-inducing drugs. Statistics demonstrate that since the telemedicine abortion program started in Iowa in 2008, chemical abortions rose to make up 64 percent of all abortions, the highest in the U.S. The FDA has determined that Mifeprex, the most common form of a chemical abortion, carries with it a risk great enough that they have required a REMS (Risk Evaluation Mitigation Strategies) to be developed. Only approximately 5% of all the FDA approved medications are currently required to have a REMS. This legislation would ensure that abortion-inducing drugs could only be provided in-person by the prescribing physician.
Ohio State Senator (R)